The Experience of Ambroxol and Acetylcysteine Combination Use for Patients with COPD

Author: 
Monogarova N.E.
Nozology: 
chronic obstructive pulmonary disease (COPD)
Subject: 
diseases of the respiratory system
File: 

Monogarova N.E., MD, A.V .Glukhov, T.V. Zakomoldina, T.V .Kugaevskaya, Kabanets N.S., MD, T.M. Belokon, Ph.D., V.N. Tkachenko
Donetsk National Medical University n.a. M. Gorky, Donetsk Regional Clinical Territorial Medical Association

Conclusions

Dynamics of clinical symptoms and indicators of external respiration function demonstrates the effectiveness of the medical product Helpex®Breathe MoviHealth Company Switzerland, in the treatment of patients with COPD, which is primarily due to the components in its composition (ambroxol and acetylcysteine).

Helpex® Breathe including into the treatment scheme of patients with COPD enhances the clinical efficiency of treatment, significantly faster reduces the main symptoms of the disease such as coughing and shortness of breath, as well as their degree of manifestation.

Treatment of patients with COPD with Helpex® Breathe can improve respiratory function, reduces cough, shortness of breath, at the same time there is a high safety profile and good tolerability.

*the article describes the properties of Helpex® Breathe product, which is named PulmoBREATHE® since 2014

Product: 
PulmoBREATHE®